Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
Abseamed, abstained, accrual, advertising, aforementioned, allegedly, Anderson, antibody, anticoagulation, anticompetitive, array, attempt, back, Binocrit, book, Bothell, burden, Bush, captioned, Cardiac, CBE, Chancery, CIA, civil, CKD, clarification, closure, CNTO, concomitant, Connecticut, Cook, core, CRF, customary, Daiichi, deep, depreciation, Disposal, divest, dL, DSaRMAC, Eldon, enhanced, EPO, ERISA, evidentiary, Exit, extending, FDAAA, forfeited, formal, frame, fundamental, German, GHSG, golimumab, guide, Hexal, highlight, highlighting, Homeland, hormonal, inaccurate, inclusion, incremental, input, insert, involuntary, Jaffe, jointly, knowledge, Larson, Lastly, lease, lifecycle, lymphoid, lymphoproliferative, malignancy, margin, mCRC, mediator, Mendall, metabolic, Metal, Michigan, minimize, Montana, mortality, motivate, Nevada, nineteen, older, overturning, payor, perisurgery, placebo, postponement, prosecution, prove, proving, randomized, reconsideration, recover, recovery, recurrent, refocusing, refusing, remodeling, reopen, reorganization, reply, resorptive, restructure, restructuring, Retacrit, reversal, robust, Rosenblum, run, Sandoz, Sankyo, statute, subpoena, Thromboembolic, thrombovascular, TNF, tolerance, transfusion, tying, UK, unapproved, unforeseen, uniform, unreliable, ustekinumab, valid, validity, verdict, virtually, Washington, Weil, zeta
Removed:
acknowledgement, aggressive, Aktiengesellschaft, amending, Amendment, Annex, Assignment, award, Bank, Brian, Cede, certificate, certification, Chase, Citibank, Citicorp, Citigroup, confidential, Confirmation, Cyanamid, dated, David, defining, deleted, Depository, dermatologic, Director, Dr, duly, EGFr, enacted, establishing, exhibit, expiring, expiry, Fenner, Fenton, finalized, furnish, furnished, George, globally, GmbH, grown, Hedge, herewith, importation, incorporated, Incorporation, Indenture, Index, influence, infusion, institute, instruction, Issuing, ITC, JPMorgan, judge, LaSalle, Lehman, LLC, Lynch, master, maturing, McNamee, MDL, Merrill, Morgan, Morrow, nanula, Nominee, Nonqualified, omitted, OTC, par, Paying, Perlmutter, Pierce, plc, PPO, proceeding, Promissory, receptor, registrant, requesting, Restated, richard, robert, Roger, Schering, Scott, senior, Smith, stabilized, Stanley, Suisse, supplemented, Syndication, therefrom, thereunto, traded, trustee, undersigned, Warrant
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.13 Fourth Amendment to the Amgen Supplemental Retirement Plan
- 10.26 First Amendment to the Amgen Inc. Executive Nonqualified Retirement Plan
- 10.31 Fourth Amendment to the Amgen Nonqualified Deferred Compensation Plan
- 10.41 Amendment to Promissory Note
- 10.80 Collaboration Agreement
- 31 Section 302 CEO and CFO Certification
- 32 Section 906 CEO and CFO Certification
Related press release
AMGN similar filings
Filing view
External links
Exhibit 10.41
AMENDMENT TO PROMISSORY NOTE
The parties hereby agree to amend certain repayment provisions set forth in the Promissory Note between Richard Nanula and Amgen Inc., executed by Richard Nanula on or about June 27, 2001, as follows: Notwithstanding anything to the contrary in Paragraph 1 of the Promissory Note, Staff Member shall pay the total amount of Principal and the remaining interest due (compounded at the rate of 5% per annum on June 27, 2008, June 27, 2009, and on the date of final repayment), in a lump sum on or before June 27, 2010.
Date: September 4, 2007 | /s/ Richard D. Nanula | |||
Richard D. Nanula | ||||
Date: August 30, 2007 | /s/ Charles V. “Chip” Bell | |||
for Amgen Inc. |